EFEarnings Feed

N

Company dossier

Neurogene Inc.

Ticker NGNECIK 0001404644SIC 2834Pharmaceutical Preparations

Add to watchlist

Exchange

Nasdaq

Entity type

operating

Fiscal year end

Dec 31

Headquarters

SEC profile ↗

Last trade

$20.44

−$9.45 (−31.62%)

Ticker

Prev close

Range (28d)

$20.06 – $34.26

Updated

Nov 24, 9:30 AM ET

Recent filings

Latest submissions

3 items

8-KAccepted Nov 13, 5:11 PM ETAcc 0001404644-25-000103
Neurogene Inc.5.4 MB
Neurogene Inc. 8-K
View filing
10-QAccepted Nov 13, 4:55 PM ETAcc 0001404644-25-000101
Neurogene Inc.7.9 MB
Neurogene Inc. 10-Q
View filing
8-KAccepted Nov 12, 12:11 PM ETAcc 0001404644-25-000098
Neurogene Inc.3.5 MB
Neurogene Inc. 8-K
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 1

Ticker roster

NGNE
Nasdaq
Exchange hub ↗

Addresses

business
535 W 24TH STREET 5TH FLOOR
NEW YORK, NY, 10011
mailing
535 W 24TH STREET 5TH FLOOR
NEW YORK, NY, 10011

Former names

Neoleukin Therapeutics, Inc.
2019-08-12 – 2023-12-06
AQUINOX PHARMACEUTICALS, INC
2013-12-19 – 2019-08-12
AQUINOX PHARMACEUTICALS (USA) INC
2007-06-25 – 2013-12-24